ROBERT W. ROSS - 15 Jun 2022 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
Issuer symbol
XLO
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
3
Filing time
17 Jun 2022, 16:06:19 UTC
Previous filing
03 Mar 2022
Next filing
05 Aug 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney